![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Even early stage ovarian cancer may show a significant number of positive lymph nodes, suggesting that metastasis plays a major role in the abysmal five-year survival rates for this disease. Better chemotherapeutic options are necessary to increase the survival rate for this disease. This month’s cover shows the expression of MUC1 in ovarian cancer tissues. In this issue of Cancer Biology & Therapy, Song and colleagues target MUC1 expressing ovarian cancer cells with a Bismuth-213 tagged Anti- MUC1 monoclonal antibody and show that one injection of the agent can prolong survival by 25 days in mice. Additional details can be found in the article by Song and colleagues.